BC
CVS icon

Barrett & Company’s CVS Health CVS Stock Holding History

Barrett & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Sell
4,364
-193
-4% -$14.9K 0.11% 111
2025
Q4 		$362K Sell
4,557
-997
-18% -$78.6K 0.12% 99
2025
Q3 		$419K Buy
5,554
+4
+0.1% +$274 0.14% 91
2025
Q2 		$383K Buy
5,550
+3
+0.1% +$197 0.14% 97
2025
Q1 		$376K Sell
5,547
-131
-2% -$7.84K 0.16% 94
2024
Q4 		$255K Sell
5,678
-496
-8% -$27.8K 0.11% 120
2024
Q3 		$388K Sell
6,174
-312
-5% -$18.2K 0.17% 89
2024
Q2 		$383K Sell
6,486
-2,922
-31% -$183K 0.17% 87
2024
Q1 		$750K Buy
9,408
+18
+0.2% +$1.38K 0.36% 54
2023
Q4 		$741K Sell
9,390
-242
-3% -$17.2K 0.4% 54
2023
Q3 		$673K Sell
9,632
-2,047
-18% -$145K 0.4% 55
2023
Q2 		$807K Buy
11,679
+314
+3% +$22.3K 0.47% 44
2023
Q1 		$845K Buy
11,365
+331
+3% +$27.8K 0.53% 41
2022
Q4 		$1.03M Hold
11,034
– – 0.68% 33
2022
Q3 		$1.03M Buy
+11,034
New +$1.09M 0.68% 33

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrett & Company's CVS Position: Q1 2026 in Review

Barrett & Company reduced its CVS Health (CVS) stake by 4.2% in Q1 2026, selling an estimated $14.9K and leaving 4,364 shares worth $313K. The position accounts for 0.11% of the portfolio, ranked #111.

Barrett & Company first reported a position in CVS in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.03M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Barrett & Company held 4,364 shares of CVS Health worth $313K as of Q1 2026.
  • Barrett & Company sold 193 CVS Health shares in Q1 2026, an estimated $14.9K.
  • CVS Health made up 0.11% of Barrett & Company's portfolio in Q1 2026, its #111 holding.
  • Barrett & Company first reported a position in CVS Health in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's CVS Health position peaked at $1.03M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.